Standard

Epicardial and endothelial cell activation concurs with extracellular matrix remodeling in atrial fibrillation. / van den Berg, Nicoline W E; Kawasaki, Makiri; Fabrizi, Benedetta et al.

In: Clinical and translational medicine, Vol. 11, No. 11, 11.2021, p. e558.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

APA

Vancouver

van den Berg NWE, Kawasaki M, Fabrizi B, Nariswari FA, Verduijn AC, Neefs J et al. Epicardial and endothelial cell activation concurs with extracellular matrix remodeling in atrial fibrillation. Clinical and translational medicine. 2021 Nov;11(11):e558. doi: 10.1002/ctm2.558

Author

van den Berg, Nicoline W E ; Kawasaki, Makiri ; Fabrizi, Benedetta et al. / Epicardial and endothelial cell activation concurs with extracellular matrix remodeling in atrial fibrillation. In: Clinical and translational medicine. 2021 ; Vol. 11, No. 11. pp. e558.

BibTeX

@article{9895004365b449a6b33061119c621b6c,
title = "Epicardial and endothelial cell activation concurs with extracellular matrix remodeling in atrial fibrillation",
abstract = "BACKGROUND: Improved understanding of the interconnectedness of structural remodeling processes in atrial fibrillation (AF) in patients could identify targets for future therapies.METHODS: We present transcriptome sequencing of atrial tissues of patients without AF, with paroxysmal AF, and persistent AF (total n = 64). RNA expression levels were validated in the same and an independent cohort with qPCR. Biological processes were assessed with histological and immunohistochemical analyses.RESULTS: In AF patients, epicardial cell gene expression decreased, contrasting with an upregulation of epithelial-to-mesenchymal transition (EMT) and mesenchymal cell gene expression. Immunohistochemistry demonstrated thickening of the epicardium and an increased proportion of (myo)fibroblast-like cells in the myocardium, supporting enhanced EMT in AF. We furthermore report an upregulation of endothelial cell proliferation, angiogenesis, and endothelial signaling. EMT and endothelial cell proliferation concurred with increased interstitial (myo)fibroblast-like cells and extracellular matrix gene expression including enhanced tenascin-C, thrombospondins, biglycan, and versican. Morphological analyses discovered increased and redistributed glycosaminoglycans and collagens in the atria of AF patients. Signaling pathways, including cell-matrix interactions, PI3K-AKT, and Notch signaling that could regulate mesenchymal cell activation, were upregulated.CONCLUSION: Our results suggest that EMT and endothelial cell proliferation work in concert and characterize the (myo)fibroblast recruitment and ECM remodeling of AF. These processes could guide future research toward the discovery of targets for AF therapy.",
author = "{van den Berg}, {Nicoline W E} and Makiri Kawasaki and Benedetta Fabrizi and Nariswari, {Fransisca A} and Verduijn, {Arianne C} and Jolien Neefs and Robin Wesselink and Al-Shama, {Rushd F M} and {van der Wal}, {Allard C} and {de Boer}, {Onno J} and Jan Aten and Driessen, {Antoine H G} and Aldo Jongejan and {de Groot}, {Joris R}",
note = "{\textcopyright} 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.",
year = "2021",
month = nov,
doi = "10.1002/ctm2.558",
language = "English",
volume = "11",
pages = "e558",
journal = "Clinical and translational medicine",
issn = "2001-1326",
publisher = "Springer Verlag",
number = "11",

}

RIS

TY - JOUR

T1 - Epicardial and endothelial cell activation concurs with extracellular matrix remodeling in atrial fibrillation

AU - van den Berg, Nicoline W E

AU - Kawasaki, Makiri

AU - Fabrizi, Benedetta

AU - Nariswari, Fransisca A

AU - Verduijn, Arianne C

AU - Neefs, Jolien

AU - Wesselink, Robin

AU - Al-Shama, Rushd F M

AU - van der Wal, Allard C

AU - de Boer, Onno J

AU - Aten, Jan

AU - Driessen, Antoine H G

AU - Jongejan, Aldo

AU - de Groot, Joris R

N1 - © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

PY - 2021/11

Y1 - 2021/11

N2 - BACKGROUND: Improved understanding of the interconnectedness of structural remodeling processes in atrial fibrillation (AF) in patients could identify targets for future therapies.METHODS: We present transcriptome sequencing of atrial tissues of patients without AF, with paroxysmal AF, and persistent AF (total n = 64). RNA expression levels were validated in the same and an independent cohort with qPCR. Biological processes were assessed with histological and immunohistochemical analyses.RESULTS: In AF patients, epicardial cell gene expression decreased, contrasting with an upregulation of epithelial-to-mesenchymal transition (EMT) and mesenchymal cell gene expression. Immunohistochemistry demonstrated thickening of the epicardium and an increased proportion of (myo)fibroblast-like cells in the myocardium, supporting enhanced EMT in AF. We furthermore report an upregulation of endothelial cell proliferation, angiogenesis, and endothelial signaling. EMT and endothelial cell proliferation concurred with increased interstitial (myo)fibroblast-like cells and extracellular matrix gene expression including enhanced tenascin-C, thrombospondins, biglycan, and versican. Morphological analyses discovered increased and redistributed glycosaminoglycans and collagens in the atria of AF patients. Signaling pathways, including cell-matrix interactions, PI3K-AKT, and Notch signaling that could regulate mesenchymal cell activation, were upregulated.CONCLUSION: Our results suggest that EMT and endothelial cell proliferation work in concert and characterize the (myo)fibroblast recruitment and ECM remodeling of AF. These processes could guide future research toward the discovery of targets for AF therapy.

AB - BACKGROUND: Improved understanding of the interconnectedness of structural remodeling processes in atrial fibrillation (AF) in patients could identify targets for future therapies.METHODS: We present transcriptome sequencing of atrial tissues of patients without AF, with paroxysmal AF, and persistent AF (total n = 64). RNA expression levels were validated in the same and an independent cohort with qPCR. Biological processes were assessed with histological and immunohistochemical analyses.RESULTS: In AF patients, epicardial cell gene expression decreased, contrasting with an upregulation of epithelial-to-mesenchymal transition (EMT) and mesenchymal cell gene expression. Immunohistochemistry demonstrated thickening of the epicardium and an increased proportion of (myo)fibroblast-like cells in the myocardium, supporting enhanced EMT in AF. We furthermore report an upregulation of endothelial cell proliferation, angiogenesis, and endothelial signaling. EMT and endothelial cell proliferation concurred with increased interstitial (myo)fibroblast-like cells and extracellular matrix gene expression including enhanced tenascin-C, thrombospondins, biglycan, and versican. Morphological analyses discovered increased and redistributed glycosaminoglycans and collagens in the atria of AF patients. Signaling pathways, including cell-matrix interactions, PI3K-AKT, and Notch signaling that could regulate mesenchymal cell activation, were upregulated.CONCLUSION: Our results suggest that EMT and endothelial cell proliferation work in concert and characterize the (myo)fibroblast recruitment and ECM remodeling of AF. These processes could guide future research toward the discovery of targets for AF therapy.

U2 - 10.1002/ctm2.558

DO - 10.1002/ctm2.558

M3 - Article

C2 - 34841686

VL - 11

SP - e558

JO - Clinical and translational medicine

JF - Clinical and translational medicine

SN - 2001-1326

IS - 11

ER -

ID: 21273589